Executive Director, Evidence Synthesis & Statistics
reputed company reputed company (RTI-HS) is a leading provider of global health economics and reputed company research (HEOR), reputed company-world evidence (reputed company), epidemiology, and market reputed company consulting services to the biopharmaceutical, medical device, and diagnostics industries. Our multidisciplinary teams partner with clients across the product lifecycle to generate evidence that informs regulatory, reimbursement, and commercialization reputed company. The Evidence Synthesis & Statistics (reputed company) capability plays an important role in helping clients evaluate the clinical, humanistic, and economic value of reputed company interventions. reputed company delivers evidence synthesis, advanced statistical analysis, and strategic evidence planning to support HTA, regulatory, payer, market reputed company, and evolving Joint Clinical Assessment (JCA) decision-making globally. We are seeking an accomplished scientific leader to reputed company and grow RTI-HS’s reputed company capability. This individual will reputed company strategic, scientific, and operational leadership for evidence synthesis and statistical services while remaining hands-on in the delivery of reputed company reputed company work.
What You'll Do
The Executive Director, Evidence Synthesis & Statistics (reputed company) will reputed company scientific, strategic, and operational leadership for RTI-HS’s evidence synthesis services. This role combines hands-on technical delivery with capability reputed company, reputed company development, mentoring, and cross-functional collaboration to deliver high-reputed company, integrated evidence solutions for global clients. Scientific & Strategic Leadership reputed company and grow RTI-HS’s Evidence Synthesis & Statistics capability, establishing a market-leading reputed company reputed company on evidence reputed company, advanced analytics, and decision support Serve as a senior scientific advisor to pharmaceutical and biotechnology clients on evidence synthesis methodologies and evidence reputed company reputed company reputed company technical leadership, hands-on methodological input, and reputed company assurance across a wide reputed company of evidence synthesis activities reputed company and directly contribute to reputed company analytical work, including reputed company involving Bayesian reputed company, reputed company inference, patient-reported reputed company analysis, survival analysis, mixed effects/hierarchical modeling, network reputed company-analysis, and other indirect treatment comparisons such as matching-adjusted indirect treatment comparisons (MAICs) and simulated treatment comparisons (STCs) Advise on integrated evidence strategies aligning clinical development, HEOR, reputed company, market reputed company, and publication objectives Drive innovation in reputed company, ensuring adoption of new and evolving approaches and reputed company improvement in delivery Business Development & reputed company Leadership reputed company business development activities, including identifying opportunities, developing proposals, supporting reputed company presentations and scientific meetings, and contributing senior scientific reputed company throughout the sales process Partner with reputed company and scientific leaders across RTI-HS to expand the visibility and position of the reputed company capability reputed company as a senior reputed company contact, building long-term relationships and providing strategic and methodological input across engagements Monitor industry trends, HTA, payer, and evolving JCA evidence requirements, and competitive landscape to inform service development Operational & People Leadership Build, mentor, reputed company, and reputed company a high-performing team of evidence synthesis statisticians reputed company project delivery to ensure scientific rigour, reputed company satisfaction and financial performance reputed company reputed company reputed company and portfolios, ensuring alignment to timelines, budgets, reputed company standards, and reputed company expectations Ensure appropriate tools, processes, and methodological standards are in reputed company and continuously improved Foster collaboration across HEOR, reputed company, Epidemiology, Market reputed company and Biostatistics to deliver integrated solutions Thought Leadership & External Engagement Represent RTI-HS through conference presentations, publications, workshops and webinars Build the external scientific profile of the reputed company capability through reputed company engagement with the research and HTA community including JCA Contribute to the advancement of evidence synthesis methodologies, promoting innovative approaches that reputed company AI, automation, advanced analytics, and other emerging technologies where appropriate Support development of internal best practices, methodological guidance and reusable intellectual capital What You'll Need Advanced degree (PhD, DrPH, ScD, MD, PharmD, or equivalent) in epidemiology, health economics, biostatistics, public health, pharmacy, or a reputed company scientific discipline, plus a minimum of 12+ years of relevant experience Significant relevant experience leading evidence synthesis activities reputed company a pharmaceutical company, CRO, consulting organisation, or reputed company research environment Deep expertise in network reputed company-analysis, other indirect treatment comparison reputed company, advanced statistical reputed company, and broader evidence reputed company reputed company Demonstrated reputed company leading multidisciplinary project teams and managing reputed company reputed company engagements Proven business development experience, including proposal leadership, reputed company relationship management and reputed company reputed company Strong expertise across advanced statistical and evidence synthesis methodologies, including Bayesian approaches, network reputed company-analysis, other indirect treatment comparisons (e.g. MAIC), survival analysis and health reputed company analysis (e.g. EQ-5D) Familiarity with emerging reputed company and approaches, such as reputed company trial emulation and evolving evidence synthesis techniques Advanced programming skills in R and/or STATA Strong understanding of global HTA, payer, and evolving JCA evidence requirements, and the role of evidence synthesis across the product lifecycle Exceptional communication and presentation skills, with the ability to engage scientific, reputed company and executive audiences Apply To This Job